Jesper Ryg(@JesperRyg) 's Twitter Profileg
Jesper Ryg

@JesperRyg

Clinical Professor Geriatric Medicine UniversitySouthernDenmark/OdenseUniversityHospital. Spec interest: Falls, frailty, onco-geriatric, appropiate prescriping

ID:1214260488592187392

calendar_today06-01-2020 19:01:53

740 Tweets

597 Followers

456 Following

Follow People
Age_and_Ageing(@Age_and_Ageing) 's Twitter Profile Photo

Congratulations Roy! We are delighted for your appointment to Editor of Age and Ageing and for the next chapter for our journal. Huge thanks to Rowan Harwood for his major contributions over his 6-yr term as Editor. We will miss you. OUP Medicine

account_circle
Jesper Ryg(@JesperRyg) 's Twitter Profile Photo

New AI study in Nature Medicine
AI-enabled electrocardiography alert intervention and all-cause mortality: a pragmatic randomized clinical trial

account_circle
JAMA(@JAMA_current) 's Twitter Profile Photo

Approximately 30% of adults aged 65 years or older experience at least 1 fall annually. This article summarizes a 2022 clinical practice guideline on falls prevention and management in older adults from the World Falls Guidelines Initiative. ja.ma/3UFn1uV

Approximately 30% of adults aged 65 years or older experience at least 1 fall annually. This article summarizes a 2022 clinical practice guideline on falls prevention and management in older adults from the World Falls Guidelines Initiative. ja.ma/3UFn1uV
account_circle
Jesper Ryg(@JesperRyg) 's Twitter Profile Photo

Arbejder du i sundhedsvæsenet med ældre borgere/patienter?

Stor europæisk undersøgelse har brug for dine inputs

Spørgeskema findes på dansk
cost-programming.eu/survey

Læs uddybende engelsk beskrivelse👇🏻👇🏻👇🏻 bgs.org.uk/blog/seeking-t…

account_circle
Jesper Ryg(@JesperRyg) 's Twitter Profile Photo

It was a great pleasure to be part of your supervisor team 🤩 You performed amazing Gabor 🥳💪🏻👏🏻

Looking forward to many future studies😀😀

account_circle
Overlægeforeningen(@Overlgeforening) 's Twitter Profile Photo

Stor succes: Kræftpatienters dødelighed faldt 2% hvert eneste år fra 2010-2021. Men der mangler kapacitet. Brug for variabel behandlingsgaranti: 'Vi skal have evidens for hvor det skal gå stærkt og hvor det kan gå knapt så stærkt' Michael Borre dagensmedicin.dk/formand-for-kr…

account_circle
Jesper Ryg(@JesperRyg) 's Twitter Profile Photo

“Bedre kræftbehandling til ældre”

Mange Inspirerende indlæg på dagens temadag hos ⁦Kræftens Bekæmpelse⁩ ⁦arrangeret af ⁦DCCC Age

Tværfagligt - tværsektorielt - og på tværs af specialer

“Bedre kræftbehandling til ældre” Mange Inspirerende indlæg på dagens temadag hos ⁦@cancer_dk⁩ ⁦arrangeret af ⁦@DcccAge⁩ Tværfagligt - tværsektorielt - og på tværs af specialer
account_circle
AMA Media(@ama_media) 's Twitter Profile Photo

This year's theme is 'Ask because you care', which seeks to empower older Australians and Australians living with a disability to have conversations with their doctor about whether any of their medicines could be doing more harm than good. SHPA

This year's #MedsAware theme is 'Ask because you care', which seeks to empower older Australians and Australians living with a disability to have conversations with their doctor about whether any of their medicines could be doing more harm than good. @the_shpa
account_circle
EuGMS - European Geriatric Medicine Society(@EuGMSSociety) 's Twitter Profile Photo

👏 Welcome our President-Elect, Tahir Masud! 🇬🇧 who wants to see EuGMS become even more influential 📢 and become a popular speciality ⚕️ for young doctors to specialize in.

Tash Masud

👏 Welcome our President-Elect, Tahir Masud! 🇬🇧 who wants to see EuGMS become even more influential 📢 and #GeriatricMedicine become a popular speciality ⚕️ for young doctors to specialize in. #EuGMS #geriatrics #olderpeople @TashMasud
account_circle
EuGMS - European Geriatric Medicine Society(@EuGMSSociety) 's Twitter Profile Photo

📣 If you are an you still have two weeks to apply for the second edition ➡️ tinyurl.com/4hw4vwwz. Get inspired with the first edition final reports.

@‌EkdahlAnne
@‌giuse_testa

account_circle
Alberto J Espay(@AlbertoEspay) 's Twitter Profile Photo

In two decades of anti-amyloid trials in (2002-2023), placebo emerges as the historic winner.
Do No Harm: is an accident, not a victory.
Presented today at , Bethesda, ASENT.org.

In two decades of anti-amyloid trials in #Alzheimers (2002-2023), placebo emerges as the historic winner. Do No Harm: #Lecanemab is an accident, not a victory. Presented today at #ASENT, Bethesda, @ASENT_Org.
account_circle